4.6 Article

The expression pattern of immune-related genes and characterization of tumor immune microenvironment: predicting prognosis and immunotherapeutic effects in cutaneous melanoma

Journal

WORLD JOURNAL OF SURGICAL ONCOLOGY
Volume 20, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12957-022-02767-z

Keywords

Immune; Melanoma; Tumor immune microenvironment; Immunotherapy; TCGA

Funding

  1. Medical Guidance Project of Science and Technology Commission of Shanghai Municipality [19411962300]
  2. special clinical research project of Health Commission of Shanghai Municipal [201940400]

Ask authors/readers for more resources

This study comprehensively evaluated the expression pattern of immune-related genes in cutaneous melanoma and their correlation with the tumor immune microenvironment. The study identified three immune subtypes with different survival outcomes and found that IRGscore can serve as an independent predictor for immunotherapy and prognosis in melanoma patients.
Background Increasing evidences have revealed the tumor immune microenvironment not only has vital impacts on the origin, progression, and metastasis of tumors significantly but also influences the response to immunotherapy. Nonetheless, to date, the well-rounded expression pattern of immune-related genes in cutaneous melanoma and the comprehensive characterization of tumor immune microenvironment remain not clearly elucidated. Method We comprehensively evaluated the well-rounded expression pattern of immune-related genes of 686 patients with cutaneous melanoma based on immune-related genes with prognostic value and systematically correlated the expression pattern of these genes with the comprehensive characterization of tumor immune microenvironment. The IRGscore was constructed to quantify immunological function of individual using principal component analysis algorithms. Result Three distinct immune subtypes were determined with obvious survival differences. Melanoma patients with high IRGscore was characterized by comprehensive suppression of immune function, showing much poorer prognosis and efficacy for immunotherapy, while the low IRGscore means the robust activation of immune function and the better effect of immunotherapy, which may be responsible for a better prognosis. Besides, the prognostic ability of IRGscore was further validated by the independent dataset of stomach cancers. Furthermore, the predictive effect of immunotherapeutic benefits of IRGscore was demonstrated by the independent dataset of melanoma patients accepting immunotherapy and another predictive model for immunotherapy. Conclusion IRGscore could serve as an independent immunotherapeutic and prognostic predictor, thereby facilitating the identification of appropriate candidates with cutaneous melanoma for immunotherapy and the formulation of individualized therapeutic approaches.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available